Back 23andMe Catalan 23andMe German 23andMe Spanish ۲۳اندمی Persian 23andMe French 23andMe HE 23andMe ID 23andMe Italian 23andMe Japanese 23andMe Korean
 | |
 Former headquarters in Sunnyvale, California | |
| Company type | Public |
|---|---|
| Nasdaq: ME | |
| Industry | |
| Founded | April 2006 |
| Founders |
|
| Headquarters | , United States |
Key people | |
| Products | |
| Services | |
| Revenue |  US$192 million (2024) |
| US$−681 million (2024) | |
| US$−666 million (2024) | |
| Total assets | US$395 million (2024) |
| Total equity | US$189 million (2024) |
Number of employees | 582 (2024) |
| Website | 23andme |
| Footnotes / references Financials as of March 31, 2024[update].[1] | |
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California.[1] It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping,[2] to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.[3]
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use.[4] Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.[5][6]
The company had a previously fraught relationship with the United States Food and Drug Administration (FDA) due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval.[7][8] 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014,[9][10][11] and in the UK since December 2014.[12]
23andMe became a publicly traded company, via a merger with a Special Purpose Aquisition Company (SPAC) in 2021 and soon had a market capitalization of US$6 billion.[13] By 2024, its valuation had fallen to 2% of that peak.[13] On September 17, 2024, all seven independent directors of the company resigned, voicing concerns about the strategic direction of the company and Wojcicki's stated intention to take the company private.[14][15] Users were concerned about the security of their genetic data, and were trying to delete it from the company's archives only to find out that it holds onto the data for three years before deleting to comply with "legal obligations".[16]
- ^ a b "23andMe Holding Co. Fiscal 2024 Annual Report (Form 10-K)". U.S. Securities and Exchange Commission. May 30, 2024.
- ^ Cite error: The named reference
Wired2007was invoked but never defined (see the help page). - ^ "Fact Sheet". 23andMe. Archived from the original on January 19, 2013. Retrieved November 27, 2013.
- ^ "Autosomal SNP comparison chart - ISOGG Wiki". isogg.org. Retrieved September 4, 2022.
- ^ Cite error: The named reference
Timewas invoked but never defined (see the help page). - ^ Janzen, Tim; et al. "Family Tree DNA Learning Center". Autosomal DNA testing comparison chart. Gene by Gene.
- ^ Herper, Matthew (December 5, 2013). "23andMe Stops Offering Genetic Tests Related to Health". Forbes. Archived from the original on February 9, 2014. Retrieved December 6, 2013.
- ^ Pollack, Andrew (October 21, 2015). "23andMe Will Resume Giving Users Health Data". The New York Times. ISSN 0362-4331. Archived from the original on March 4, 2016. Retrieved October 21, 2015.
- ^ Ubelacker, Sheryl (October 1, 2014). "U.S. company launches genetic health and ancestry info service in Canada". Winnipeg Free Press. The Canadian Press. Retrieved October 7, 2014.
- ^ Hansen, Darah (October 2, 2014). "5Q: Anne Wojcicki, CEO 23andMe on knowing your DNA data (and being married to the boss of Google)". Yahoo Finance Canada. Retrieved October 7, 2014.
- ^ "23andme genetic testing service raises ethical questions". CBC News. October 2, 2014. Retrieved October 7, 2014.
- ^ Roberts, Michelle; Rincon, Paul (December 2, 2014). "Controversial DNA test comes to UK". BBC News. Retrieved December 2, 2014.
- ^ a b Winkler, Rolfe (January 31, 2024). "23andMe's Fall From $6 Billion to Nearly $0". Wall Street Journal.
- ^ Morrow, Allison (September 20, 2024). "What happened to 23andMe?". CNN Business. Retrieved October 9, 2024.
- ^ Winkler, Rolfe (September 17, 2024). "23andMe Board Resigns in New Blow to DNA-Testing Company". Wall Street Journal.
- ^ Purtill, James (October 16, 2024). "As 23andMe faces bankruptcy, your genetic data could be sold to highest bidder". ABC News. Retrieved January 17, 2025.